Proliferative Highly Differentiated Follicular Carcinoma Of Ovarian Origin (Hdfco) Presenting Long After Bilateral Oophorectomy
ABSTRACT: Objective: The malignant spread of histologically benign struma ovarii was historically referred to as peritoneal strumosis. Recently, highly differentiated follicular carcinoma of ovarian origin (HDFCO) was proposed as a more accurate diagnostic term for this rare disease. We report the u...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-01-01
|
Series: | AACE Clinical Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2376060520301899 |
id |
doaj-8c629082f12345f8b1066641bc4bf4fb |
---|---|
record_format |
Article |
spelling |
doaj-8c629082f12345f8b1066641bc4bf4fb2021-04-30T07:23:53ZengElsevierAACE Clinical Case Reports2376-06052017-01-0133e264e268Proliferative Highly Differentiated Follicular Carcinoma Of Ovarian Origin (Hdfco) Presenting Long After Bilateral OophorectomyNatalie M. Liu, BS0Neda Moatamed, MD1Racquel S. Bueno, MD2Wendy L. Sacks, MD3From the 1Department of Pathology and Laboratory Medicine, University of California, Los Angeles, CaliforniaFrom the 1Department of Pathology and Laboratory Medicine, University of California, Los Angeles, CaliforniaDepartment of Surgery, Ekahi Central Medical Center, Honolulu, HawaiiDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.; Address correspondence to Dr. Wendy L. Sacks, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048.ABSTRACT: Objective: The malignant spread of histologically benign struma ovarii was historically referred to as peritoneal strumosis. Recently, highly differentiated follicular carcinoma of ovarian origin (HDFCO) was proposed as a more accurate diagnostic term for this rare disease. We report the unusual case presentation of a woman with HDFCO and the subsequent management of her cancer.Methods: Her interventions included abdominal surgery, postoperative laboratory tests, imaging, thyroidectomy, radioactive iodine-123 (RAI-123) diagnostic screening, and thyroid function studies.Results: A 72-year-old Chinese female was diagnosed with metastatic HDFCO approximately 30 years after hysterectomy and bilateral oophorectomy. While undergoing evaluation for an upper gastrointestinal bleed, a computed tomography scan revealed a 10 cm pelvic mass and multiple other peritoneal tumors. She underwent tumor debulking surgery, and the pathology was interpreted at two institutions; both made the diagnosis of a very well-differentiated follicular carcinoma arising in struma ovarii. Lab tests revealed hyperthyroidism and RAI-123 uptake confirmed tumor production of thyroid hormone. A total thyroidectomy was performed in anticipation of treatment with radioactive iodine-131 (RAI-131). However, the patient remained clinically asymptomatic and, therefore, neither additional tumor debulking nor RAI-131 treatment were performed. No disease progression has been noted for over 3 years.Conclusion: This case highlights the potentially slow-growing nature of HDFCO which, in such cases, may be suited to less aggressive disease management.Abbreviations: CT computed tomography; Hb hemoglobin; HDFCO highly differentiated follicular carcinoma of ovarian origin; RAI-123 radioactive iodine-123; RAI-131 radioactive iodine-131; T3 triiodothyronine; T4 thyroxine; TSH thyroid-stimulating hormone;http://www.sciencedirect.com/science/article/pii/S2376060520301899 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Natalie M. Liu, BS Neda Moatamed, MD Racquel S. Bueno, MD Wendy L. Sacks, MD |
spellingShingle |
Natalie M. Liu, BS Neda Moatamed, MD Racquel S. Bueno, MD Wendy L. Sacks, MD Proliferative Highly Differentiated Follicular Carcinoma Of Ovarian Origin (Hdfco) Presenting Long After Bilateral Oophorectomy AACE Clinical Case Reports |
author_facet |
Natalie M. Liu, BS Neda Moatamed, MD Racquel S. Bueno, MD Wendy L. Sacks, MD |
author_sort |
Natalie M. Liu, BS |
title |
Proliferative Highly Differentiated Follicular Carcinoma Of Ovarian Origin (Hdfco) Presenting Long After Bilateral Oophorectomy |
title_short |
Proliferative Highly Differentiated Follicular Carcinoma Of Ovarian Origin (Hdfco) Presenting Long After Bilateral Oophorectomy |
title_full |
Proliferative Highly Differentiated Follicular Carcinoma Of Ovarian Origin (Hdfco) Presenting Long After Bilateral Oophorectomy |
title_fullStr |
Proliferative Highly Differentiated Follicular Carcinoma Of Ovarian Origin (Hdfco) Presenting Long After Bilateral Oophorectomy |
title_full_unstemmed |
Proliferative Highly Differentiated Follicular Carcinoma Of Ovarian Origin (Hdfco) Presenting Long After Bilateral Oophorectomy |
title_sort |
proliferative highly differentiated follicular carcinoma of ovarian origin (hdfco) presenting long after bilateral oophorectomy |
publisher |
Elsevier |
series |
AACE Clinical Case Reports |
issn |
2376-0605 |
publishDate |
2017-01-01 |
description |
ABSTRACT: Objective: The malignant spread of histologically benign struma ovarii was historically referred to as peritoneal strumosis. Recently, highly differentiated follicular carcinoma of ovarian origin (HDFCO) was proposed as a more accurate diagnostic term for this rare disease. We report the unusual case presentation of a woman with HDFCO and the subsequent management of her cancer.Methods: Her interventions included abdominal surgery, postoperative laboratory tests, imaging, thyroidectomy, radioactive iodine-123 (RAI-123) diagnostic screening, and thyroid function studies.Results: A 72-year-old Chinese female was diagnosed with metastatic HDFCO approximately 30 years after hysterectomy and bilateral oophorectomy. While undergoing evaluation for an upper gastrointestinal bleed, a computed tomography scan revealed a 10 cm pelvic mass and multiple other peritoneal tumors. She underwent tumor debulking surgery, and the pathology was interpreted at two institutions; both made the diagnosis of a very well-differentiated follicular carcinoma arising in struma ovarii. Lab tests revealed hyperthyroidism and RAI-123 uptake confirmed tumor production of thyroid hormone. A total thyroidectomy was performed in anticipation of treatment with radioactive iodine-131 (RAI-131). However, the patient remained clinically asymptomatic and, therefore, neither additional tumor debulking nor RAI-131 treatment were performed. No disease progression has been noted for over 3 years.Conclusion: This case highlights the potentially slow-growing nature of HDFCO which, in such cases, may be suited to less aggressive disease management.Abbreviations: CT computed tomography; Hb hemoglobin; HDFCO highly differentiated follicular carcinoma of ovarian origin; RAI-123 radioactive iodine-123; RAI-131 radioactive iodine-131; T3 triiodothyronine; T4 thyroxine; TSH thyroid-stimulating hormone; |
url |
http://www.sciencedirect.com/science/article/pii/S2376060520301899 |
work_keys_str_mv |
AT nataliemliubs proliferativehighlydifferentiatedfollicularcarcinomaofovarianoriginhdfcopresentinglongafterbilateraloophorectomy AT nedamoatamedmd proliferativehighlydifferentiatedfollicularcarcinomaofovarianoriginhdfcopresentinglongafterbilateraloophorectomy AT racquelsbuenomd proliferativehighlydifferentiatedfollicularcarcinomaofovarianoriginhdfcopresentinglongafterbilateraloophorectomy AT wendylsacksmd proliferativehighlydifferentiatedfollicularcarcinomaofovarianoriginhdfcopresentinglongafterbilateraloophorectomy |
_version_ |
1721498493700276224 |